What is the Share Price of Indraprastha Medical Corporation Ltd?
- Answer Field
-
The share price of Indraprastha Medical Corporation Ltd for NSE is ₹ 397 and for BSE is ₹ 397.1.
Open Your Free Demat Account
Enjoy low brokerage on delivery trades
BAJAJ BROKING
Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
INDRAPRASTHA MEDICAL CORP SHARE PRICE
Sector: Healthcare
-6.25
(-1.54%)
1D
Last updated: Apr 30 2025 03:29 PM
4751
532150
INDRAMEDCO
Compare to
View
Display
Studies
No Data Available
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
INDRAPRASTHA MEDICAL CORP performance
Open Price
₹ 401.85
Prev. Close
₹ 403.25
Volume (Shares)
127211.00
Total traded value
₹ 507.69
Upper Circuit
₹ 483.90
Lower Circuit
₹ 322.60
INDRAPRASTHA MEDICAL CORP Share Price Update
As of the latest trading session, INDRAPRASTHA MEDICAL CORP share price is currently at ₹ 397, which is down by ₹ -6.25 from its previous closing. Today, the stock has fluctuated between ₹ 393.45 and ₹ 406.35. Over the past year, INDRAPRASTHA MEDICAL CORP has achieved a return of 47.27 %. In the last month alone, the return has been 2.60 %. Read More...
INDRAPRASTHA MEDICAL CORP fundamentals
-
Market cap (Cr)
3,658.70
-
P/E Ratio (TTM)
24.04
-
Beta
1.10
-
Book Value / share
57.20
-
Return on equity
28.92%
-
EPS (TTM)
16.49
-
Dividend yield
1.14%
-
Net profit/quarter (Cr)
32.81
-
Market cap (Cr)
3,633.90
-
P/E Ratio (TTM)
24.04
-
Beta
1.05
-
Book Value / share
57.20
-
Return on equity
28.92%
-
EPS (TTM)
16.49
-
Dividend yield
1.14%
-
Net profit/quarter (Cr)
32.81
INDRAPRASTHA MEDICAL CORP Financials
Key Results
Key Ratios
Balance sheet
Cash Flow
Competition
Revenue
Net income
| Particulars | DEC 2024 (Values in Cr) |
|---|---|
| Revenue | 324.93 |
| Operating Expense | 285.53 |
| Net Profit | 32.81 |
| Net Profit Margin (%) | 10.09 |
| Earnings Per Share (EPS) | 3.58 |
| EBITDA | 57.32 |
| Effective Tax Rate (%) | 26.31 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | 6992.60 | 76.74 | 13.41 | 100542.86 | 5690.80 / 7545.10 |
| FORTIS MALAR HOSPITALS LIMITED | 78.74 | 192.05 | 4.94 | 147.57 | 51.01 / 98.70 |
| SHREE PACETRONIX LTD. | 71.00 | 14.79 | 1.90 | 25.56 | 61.11 / 268.50 |
| TRANSGENE BIOTEK LTD. | 3.75 | 0.00 | 2.62 | 28.41 | 3.22 / 10.84 |
| VIMTA LABS LIMITED | 1037.40 | 37.94 | 6.72 | 2306.61 | 420.00 / 1183.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| APOLLO HOSPITALS ENTER. L | 6992.60 | 83.66 | 12.27 | 100542.86 | 5690.80 / 7545.10 |
| Surlux Diagnostic Ltd | 1.40 | 0.84 | 0.13 | 0.49 | 0.00 / 0.00 |
| CHENNAI MEENAKSHI MULTISPECIAL | 31.25 | 0.00 | -16.74 | 23.34 | 28.34 / 59.90 |
| KOVAI MEDICAL CENTER & HOSPITA | 5584.95 | 29.60 | 6.27 | 6109.94 | 3750.00 / 6400.00 |
INDRAPRASTHA MEDICAL CORP Technicals Summary
- EMA & SMA
- Resistance and Support
- Delivery and Volume
- Beta
- Price Change Analysis
399.10
-1.02
14
Bearish
2
Bullish
- 5 Days 407.40
- 26 Days 402.60
- 10 Days 409.40
- 50 Days 403.80
- 12 Days 408.80
- 100 Days 410.50
- 20 Days 404.80
- 200 Days 388.60
408.73
PIVOT
First Support
395.87First Resistance
416.12Second Support
388.48Second Resistance
428.98Third Support
375.62Third Resistance
436.37RSI
50.26ADX
10.16MACD
7.78Williams % R
-31.25Commodity Channel Index (CCI)
18.97Date
2025-04-29Week
96976.00Same Day
61988.00Month
91271.001 Year
1.103 Year
0.96Over 1 Month
2.60%
Over 1 Year
47.27%
Over 3 Months
-8.66%
Over 3 Years
83.18%
Over 6 Months
-3.90%
Over 5 Years
58.90%
INDRAPRASTHA MEDICAL CORP Share Price
Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988. The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi.
The Company's efforts culminated on 18 September 1983, when India's first corporate hospital, Apollo Hospitals in Madras, came into existence. In 1998-99, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.
During 1999-2000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases.
A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.'2001, in Delhi. This clinic also functions as a referral and sample collection centre for laboratory investigation.
A high energy linear accelerator was installed with multileaf collimeter enabling selective radiation to the affected part sparing normal tissue. A four digit telephone number '1066' was introduced by the Hospital for Emergency Medical Services and this is the first of its kind in the country. Three more super specialites namely Joint replacement,Spinal disorders and vascular surgeries have been started in the Hospital. The HIS is nearing completion and will be fully operational in the fag end of this financial year.
During October 2001 the Hospital opened the Satellite Clinic at Golf Link,New Delhi.
The new 57-bed Apollo Hospital in Noida offering secondary and tertiary services became operational in 2006. A specialized Clinic for Chest Pain under the banner Apollo Chest Pain Centre (ACPC)' was launched in three locations, Bansal Hospital in Friends Colony, Sehgal Nursing Home in Paschim Vihar and the Apollo Clinic in Vasant Kunj, New Delhi.
During 2009-10, Indraprastha Apollo Hospitals introduced Endoscopic Ultra Sonology (EUS), a major advancement in diagnosing and treating gastrointestinal and pancreato-biliary diseases. The Multi Organ Transplant unit of the Hospital performed 268 organ transplants in the financial year 2009-10 (117 liver and 151 kidney transplants). Significant renovation and upgradation work was completed during the year, which should add to patient comfort and help achieve more operational efficiencies. Among others, a new orthopaedics operation theatre, a 5-bed ICU for critical cardiac care patients, a 12 bed Multi Organ Transplant Unit for Renal Transplant patients, a Mezzanine in the atrium for ICU patient attendants and international patient lounge were commissioned. 58 patient rooms and 3 OPDs were also renovated.
A new Endoscopic Ultrasound Unit was commissioned in 2010-11. A Bone Marrow Transplant Unit, one of the highest end of medical services, was also created in the Hospital for intensive treatment and management of certain cancers like leukemia, lymphomas and also some non-cancerous diseases like thalessaemia. A multi organ transplant unit was added to the increasing organ transplant demands. Renovated four OPD wings and day care facility. An OP pharmacy, OPD billing counter, Insurance TPA help desk and ICU patient lobby have been setup for the comfort and ease of patients.
The expansion project undertaken by the Hospital was completed in 2011. In addition, a Cosmetic Centre was set up to provide aesthetic medicine on an out-patient basis. Out of the additional beds, 50 beds were commissioned. As part of the ongoing upgradation and renovation programme, a number of departments and units such as Gynecology & Pediatric OPD, Sample collection; Chemotherapeutics Admixture Room; Telemedicine Room; Fetal Medicine; Nucleic Acid Testing (NAT) Laboratory and Staff Cafeteria were refurbished to increase patient comfort and enhance operational efficiency. In order to meet the pressing demand of Dialysis and increased number of renal transplants, seven additional beds were commissioned in the Dialysis unit taking the capacity to 28. A new Out Patient Wing (OPD 2C) - with 14 Consultation rooms was commissioned in place of 28 general ward beds, to accommodate the new Consultants.
The Expansion Project undertaken by the main Hospital to add 127 additional Beds comprising of 74 single rooms, 33 general ward beds and 20 ICU beds, was completed. With the completion of the expansion project, the total bed strength of the Hospital has increased to 710 beds in 2012-13. The Apollo Institute of Robotic Surgery was launched in June, 2012 and has been performing a good number of robotic surgeries with the Da-Vinci Robotic Surgical System. The Hospital commissioned the Cosmetic Clinic in 2012.
In 2013-14, the Apollo Obesity and Metabolic Surgery (Bariatric surgery) Centre was commissioned. The Apollo Institute of Robotic Surgery, which was instituted last year, performed 173 surgeries during the year. The Renal Transplant services were commenced in September, 2013 and resulting to this, a total of 18 transplants were conducted in the Noida hospital during the year. The Pain Clinic was started in January 2014 offering integrated and comprehensive Pain Management for all kinds of pain. Given the rising burden of Non-Communicable Diseases and Diabetes, the Sugar Clinic was also started to help patients in better management of Diabetes and prevention of associated complications. The hospital also expanded its Emergency department with 10 additional beds being added along with a complete renovation. The total strength of the unit stands at 20 beds. Also, the Urology, Nephrology and Dermatology OP areas underwent renovation. A large number of equipments were replaced or upgraded in various specialities including Oncology, Fetal Medicine, Cosmetics, Cardiology and Microbiology along with OT and other equipment at the main hospital and in Noida.
Project Priceless, an Apollo wide initiative supported by inputs from Bain & Company, to improve overall patient experience and improve patient and physician advocacy for the Hospital, commenced in June, 2014. Plastic and Cosmetic Surgery: New Anti-aging procedures have been introduced such as Mid-face volumization; Skin lifting and tightening 'Ulthera procedure' for face, upper neck, lower neck and arms; and Cool Sculpting for non-invasive localized fat reduction for body contouring. In addition, a multitude of new investigation services have been started including Chromosomal Genetic Study, Contrast Enhanced Ultrasonography, etc. Various new Diagnostic or Surgical processes have also been added in different specialties such as Clot Evacuation in Urology, Tracheal or Bronchial Stent placement in Respiratory medicine, FET PET MRI for better imaging of brain tumours, Molecular Imaging, Nuclear Medicine, etc.
The Central Asia e-Network link was launched on 12th July 2015. The event featured a tele-consultation for a cardiac patient between doctors in Osh city in Southern Kyrgyzstan, in Bishkek and with Apollo Hospital and AIIMS. The Hospital completed a successful cadaver split liver transplant wherein both the parts of the liver were given to two adult recipients. This was the first split liver transplant in two adults reported in the city and the second in India.
Indraprastha Apollo Hospitals started providing Geriatric Services starting December 2016. New technique of Molecular Micro Film Array (Biofire) for rapid detection of micro-organisms in cases of meningitis/ encephalitis, sepsis, respiratory infections and gastroenteritis were introduced in Molecular Microbiology. In 2018-19, the Hospital commissioned a new state-of-the-art Chemotherapy Unit with 30 beds.
During 2021-22, the Bone Marrow Transplant (BMT) project Unit, created a dedicated wing for BMT unit with 8 single rooms, 3 general ward beds and 1 procedure room, which was commissioned in August 2021. Bronchoscopy and PFT lab were cohorted in one area to make it man-power optimal. A 25-bedded Dialysis Unit was created in the Lower Basement of the hospital to create a better patient experience. Orthopaedic operating theatre was moved from Ground Floor to the first floor so that all theatres are cohorted in one area. The Radiology Unit was renovated to improve patient experience.
The financial year 2022-23 was a year of reset for both, the clinical services, and the infrastructure. The hospital introduced a slew of differentiated clinical programmes including Structural Heart Diseases, minimally invasive and Robotic Cardiac Surgeries, Leadless pacemakers, Cardiodiagnostics like Cardiac MRI and niche Gastroenterological procedures like Third space endoscopy. Multiple cases of Total Hip replacements and many cases of complicated congenital heart diseases were carried out successfully by our team of doctors. A 71-year-old-male, diagnosed as a case of localized adenocarcinoma prostate, underwent a successful nerve sparing robotic radical prostatectomy with amniotic nerve wrap with bilateral pelvic lymph node dissection. A 61-year-old female patient successfully underwent a transcatheter mitral valve replacement (TMVR). A 64-year-old male from Fiji underwent Robotic assisted total arterial triple vessel coronary artery bypass surgery. A 28-year-old young man from Oman was treated successfully for a deformity in his left knee using 3-D printing technology. A 21-year-old male underwent a successful Robot assisted Trans-Oral surgery to remove a large parapharyngeal space tumour (tumour in the deep tissues of the neck, nerves, lymph nodes, and parts of salivary gland). A total hip arthroplasty was successfully performed on a 50-year-old. The patient was suffering with an extremely rare condition of Primary Synovial chondromatosis of the Hip'. Several new equipment were added to hospital's arsenal. The most significant investment was the ZAP-X Gyroscopic Radiosurgery system. To accommodate the increasing number of clinical services and to better patient experience, the hospital undertook a series of transformative infrastructural revamp projects including cohorting all operating theatres, creating a cohorted endoscopy suite, new dialysis suite, new international patient lounge and new Oncology OPD. A biomethanation plant was set up with a capacity of 1 Ton to enable in-house treatment of Food, Kitchen, and Biomass waste and convert the waste into Biogas and Organic Manure.
In 2024, Company performed more than 30 robotic cardiac surgeries, with zero mortality and it is working towards making Aortic surgeries easily accessible for the affected segment. A 70-year-old Australian woman with possible recurrence of ovarian/fallopian tube cancer, initially treated in 2015, underwent a laparoscopic excision of the recurrent tumor and umbilical nodule followed by dendritic cell therapy (DCT). The first robotic hip replacement using the direct anterior approach (bikini incision hip replacement) was performed for the first time in North India. An 'ascending aorta and aortic arch replacement with frozen elephant trunk' was performed in a 58-year-old Kenyan patient with an ascending aorta aneurysm with dilated aortic arch and ulcer in proximal descending aorta. All the arch branches were reimplanted onto the prosthetic graft. The part of the procedure was done on 'total circulatory arrest' using a special hybrid graft 'Thoraflex'. The first supine PCNL for renal stones is an evolutionary change in procedure and was performed for the first time in Apollo Delhi. A multidisciplinary team, including Physicists, Neurosurgeons, ENT specialists, and Oncologists, successfully treated over 30 patients with various conditions using Stereotactic Gyroscopic Radiosurgery (Zap-X) for the first time in South Asia, with ongoing active follow-up. Successful Reverse Shoulder Replacement for Neglected Proximal Humerus Fracture was a challenging case as there was severe osteoporosis with proximal humeral bone loss and atrophied shoulder girdle musculature.
Parent organization
Pratap Reddy
NSE symbol
INDRAMEDCO
Founded
1988
Board Of Directors
Prathap C Reddy
Vice Chairman
Suneeta Reddy
Non Executive Director
Sangita Reddy
Non Executive Director
Vineeta Rai
Independent Non Exe. Director
Arun Rai
Independent Non Exe. Director
Vinayak Chatterjee
Independent Non Exe. Director
Madhumita Ganguli
Independent Non Exe. Director
Menaka Gurusswamy
Independent Non Exe. Director
Salil Singhal
Independent Non Exe. Director
Mahesh Verma
Non Executive Director
P Shivakumar
Managing Director
Tejpreet S Chopra
Independent Non Exe. Director
Sandip Somany
Independent Non Exe. Director
Explore More Investment Options
Similar stocks
AATMAJ
19.8
1.04
HCG
562.45
15.75
FORTIS
685.55
18.34
SANGANI
74
1.50
MEDANTA
1197.2
19.39
RAINBOW
1372
14.69
SYNGENE
634.05
5.14
GPTHEALTH
156
-0.10
LOTUSEYE
81.22
-0.13
APOLLOHOSP
6977
-15.50
Frequently Asked Questions
What is the Market Cap of Indraprastha Medical Corporation Ltd?
- Answer Field
-
The market cap of Indraprastha Medical Corporation Ltd for NSE is ₹ 36,58.70 Cr. and for BSE is ₹ 0.0 Cr. as of now.
What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?
- Answer Field
-
The 52 Week High and Low of Indraprastha Medical Corporation Ltd for NSE is ₹ 572.00 and ₹ 211.30 and for BSE is ₹ 571.95 and ₹ 212.25.
How to Buy Indraprastha Medical Corporation Ltd share?
- Answer Field
-
You can trade in Indraprastha Medical Corporation Ltd shares with Bajaj Broking by opening a Demat Account.
What is 1 year return for Indraprastha Medical Corporation Ltd?
- Answer Field
-
The 1 year returns on the stock has been 49.16%.
What is the Current Share Price of Indraprastha Medical Corporation Ltd?
- Answer Field
-
Indraprastha Medical Corporation Ltd share price is for NSE ₹ 397 & for BSE ₹ 397.1 as on Apr 30 2025 03:29 PM.
What is the Market Cap of Indraprastha Medical Corporation Ltd Share?
- Answer Field
-
The market cap of Indraprastha Medical Corporation Ltd for NSE ₹ 36,58.70 & for BSE ₹ 0.0 as on Apr 30 2025 03:29 PM.
What is the P/E Ratio of Indraprastha Medical Corporation Ltd Share?
- Answer Field
-
As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Indraprastha Medical Corporation Ltd share is 24.04.
What is the PB ratio of Indraprastha Medical Corporation Ltd Share?
- Answer Field
-
As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Indraprastha Medical Corporation Ltd share is 57.20.
How to Buy Indraprastha Medical Corporation Ltd Share?
- Answer Field
-
You can trade in Indraprastha Medical Corporation Ltd shares with Bajaj Broking by opening a demat account.
How to Buy Indraprastha Medical Corporation Ltd Share on Bajaj Broking App?
- Answer Field
-
To buy Indraprastha Medical Corporation Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Indraprastha Medical Corporation Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found
Realated News & Articles
+91
|
Please Enter Mobile Number
Open Your Free Demat Account
Enjoy low brokerage on delivery trades
+91
|
Products
Calculator
Platforms
- footer content
Knowledge Centre
Important Links
Explore
Corporate
Discover Bajaj Broking
Follow Us
- footer content
-
TRENDING CALCULATORS AND STOCKS ON BAJAJ BROKING
TOOLS:
Popular Stock
- top-popular-on-bfsl
-
POPULAR STOCKS: Tata Motors Share Price Infosys Share Price IRFC Share Price SBI Card Share Price Cipla Share Price NBCC Share Price IDFC First Bank Share Price IRCTC Share Price PNB Share Price Vodafone Idea Share Price Axis Bank Share Price JSW Steel Share Price Bandhan Bank Share Price SBI Share Price Tata Steel Share Price ONGC Share Price Ashok Leyland Share Price Paytm Share Price Subex Share Price DLF Share Price Reliance Share Price HDFC Bank Share Price Suzlon Share Price IOC Share Price HUL Share Price Asian Paints Share Price Bank Of Baroda Share Price ITC Share Price TCS Share Price HFCL Share Price Icici Bank Share Price Tata Chemicals Share Price CDSI Share Price MRF Share Price Tata Power Share Price Adani Green share price BPCL Share Price Vedanta Share Price Dmart Share Price Hindalco Share Price LIC Share Price SAIL Share Price Adani Port Share Price IEX Share Price Nalco Share Price L&T Share Price Adani Power Share Price BHEL Share Price Bajaj Finance Share Price Canara Bank Share Price Indusind Bank Share Price Gail Share Price Yes Bank Share Price Wipro Share Price Happiest Minds Share Price Coal India Share Price Maruti Share Price Reliance Power Share Price
INDIAN INDICES: Nifty 50 Share Price SENSEX Share Price Nifty Next 50 Share Price BSE100 Share Price Nifty Bank Share Price LRGCAP Share Price Nifty 100 Share Price MIDCAP Share Price Nifty 200 Share Price SMLCAP Share Price Nifty 500 Share Price BSE500 Share Price Nifty Midcap 50 Share Price ALLCAP Share Price NIFTY SMLCAP 50 Share Price BSE200 Share Price India VIX Share Price BSEIPO Share Price